Pharma Stocks
-
Helus Pharma (HELP) begins Nasdaq trading, advances mental health drugs
01/05/2026 – 07:30 AM Helus Pharma builds on the strong foundation originally created as Cybin Inc., reflecting the Company’s ongoing…
Read More » -
Is This Boring Pharma Play Your Next Power Move?
Cencora Inc. looks boring on the surface, but its stock performance is saying something very different. Is this low-key healthcare…
Read More » -
Why This Indian Pharma Stock Is Suddenly on Everyone’s Rad
Alkem Laboratories just dropped a performance glow-up that has investors, TikTok traders, and pharma geeks watching hard. Is this India-based…
Read More » -
When Will Klaria Pharma Holding AB (publ.) (STO:KLAR) Breakeven?
We feel now is a pretty good time to analyse Klaria Pharma Holding AB (publ.)’s (STO:KLAR) business as it appears…
Read More » -
Is This Pharma Giant a Silent Stock Cheat Code?
Everyone’s busy chasing shiny AI stocks while Novartis AG quietly moves billions in the background. Is this pharma OG a…
Read More » -
Sleeper Stock or Total Flop? Here’s the Real Talk You Need
Sinopharm is moving while everyone’s doomscrolling tech. Is this low-key pharma giant a must-cop value play or a walking red…
Read More » -
Hard Look At Fidson, May&Baker, Neimeth And Mecure In 2026
Pharma Stocks: Hard Look at Fidson, May&Baker, Neimeth and Mecure in 2026 In Nigeria, healthcare, especially pharmaceuticals, remains one of…
Read More » -
Zealand Pharma A/S’ (CPH:ZEAL) Share Price Is Matching Sentiment Around Its Revenues
With a price-to-sales (or “P/S”) ratio of 3.5x Zealand Pharma A/S (CPH:ZEAL) may be sending very bullish signals at the…
Read More » -
Cipla’s Stock Tests Investor Patience As Pharma Rally Leaves It Behind
While India’s pharma index has pushed toward new highs, Cipla’s stock has drifted sideways, caught between solid fundamentals and stubborn…
Read More » -
Cipla’s Stock Tests Investor Patience As Pharma Rally Leaves It Behind
While India’s pharma index has pushed toward new highs, Cipla’s stock has drifted sideways, caught between solid fundamentals and stubborn…
Read More »